GPC3 and hepatocellular carcinoma: Glypican-3 is a heparan sulfate proteoglycan bound to a cell membrane through glycosyl-phosphatidylinositol anchor and first discovered in 2003 to be proposed as a diagnostic and prognostic biomarker for HCC [131].